These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

6431 related items for PubMed ID: 25639772

  • 1. Establishment of a novel Chinese metastatic melanoma cell line showing the new cytogenetic and biological properties.
    Yi X, Zhu G, Li Y, Liu Y, Luan Q, Dai W, Wang L, Liao W, Gao T, Li C.
    Cell Biol Int; 2015 Apr; 39(4):508-14. PubMed ID: 25639772
    [Abstract] [Full Text] [Related]

  • 2. Lymph node metastases of melanoma: challenges for BRAF mutation detection.
    Chen G, Dudley J, Tseng LH, Smith K, Gurda GT, Gocke CD, Eshleman JR, Lin MT.
    Hum Pathol; 2015 Jan; 46(1):113-9. PubMed ID: 25456393
    [Abstract] [Full Text] [Related]

  • 3. Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT.
    Daniotti M, Ferrari A, Frigerio S, Casieri P, Miselli F, Zucca E, Collini P, Della Torre G, Manoukian S, Peissel B, Bono A, Santinami M, Parmiani G, Rivoltini L, Pilotti S, Rodolfo M.
    J Invest Dermatol; 2009 Jul; 129(7):1759-68. PubMed ID: 19158841
    [Abstract] [Full Text] [Related]

  • 4. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
    Della Torre G, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot TJ, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G, Pierotti MA.
    Br J Cancer; 2001 Sep 14; 85(6):836-44. PubMed ID: 11556834
    [Abstract] [Full Text] [Related]

  • 5. Clear cell melanoma: a cutaneous clear cell malignancy.
    Pletneva MA, Andea A, Palanisamy N, Betz BL, Carskadon S, Wang M, Patel RM, Fullen DR, Harms PW.
    Arch Pathol Lab Med; 2014 Oct 14; 138(10):1328-36. PubMed ID: 25268196
    [Abstract] [Full Text] [Related]

  • 6. Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopathologic prognosticators and the BRAF status.
    Mitchell B, Leone D, Feller JK, Bondzie P, Yang S, Park HY, Mahalingam M.
    Melanoma Res; 2014 Dec 14; 24(6):621-5. PubMed ID: 25211166
    [Abstract] [Full Text] [Related]

  • 7. Is BRAF a prognostic factor in stage III skin melanoma? A retrospective study of 72 patients after positive sentinel lymph node dissection.
    Picard M, Pham Dang N, D'Incan M, Mansard S, Dechelotte P, Pereira B, Mondie JM, Barthelemy I.
    Br J Dermatol; 2014 Jul 14; 171(1):108-14. PubMed ID: 24602025
    [Abstract] [Full Text] [Related]

  • 8. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
    Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J.
    Cancer Res; 2000 Dec 15; 60(24):6864-7. PubMed ID: 11156381
    [Abstract] [Full Text] [Related]

  • 9. Molecular characterization of human cutaneous melanoma-derived cell lines.
    Ogbah Z, Puig-Butille JA, Simonetta F, Badenas C, Cervera R, Milá J, Benitez D, Malvehy J, Vilella R, Puig S.
    Anticancer Res; 2012 Apr 15; 32(4):1245-51. PubMed ID: 22493355
    [Abstract] [Full Text] [Related]

  • 10. [Clinicopathological features of metastatic melanoma in effusion cytology of serosal cavity].
    Xia Q, Chang XN, Huang B, Li XF, Luo DJ, Wang QJ, Jiang MT, Fan J, Zhou DW.
    Zhonghua Bing Li Xue Za Zhi; 2024 Aug 08; 53(8):837-842. PubMed ID: 39103266
    [Abstract] [Full Text] [Related]

  • 11. Molecular characterization of novel melanoma cell lines.
    Zanna P, Maida I, Turpin Sevilla MC, Susca FC, Filotico R, Arciuli M, Cassano N, Vena GA, Cicero R, Guida G.
    J Biol Regul Homeost Agents; 2011 Aug 08; 25(2):239-47. PubMed ID: 21880213
    [Abstract] [Full Text] [Related]

  • 12. Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B.
    Soto JL, Cabrera CM, Serrano S, López-Nevot MA.
    BMC Cancer; 2005 Apr 08; 5():36. PubMed ID: 15819981
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous knockdown of BRAF and expression of INK4A in melanoma cells leads to potent growth inhibition and apoptosis.
    Zhao Y, Zhang Y, Yang Z, Li A, Dong J.
    Biochem Biophys Res Commun; 2008 Jun 06; 370(3):509-13. PubMed ID: 18402768
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
    Long GV, Wilmott JS, Capper D, Preusser M, Zhang YE, Thompson JF, Kefford RF, von Deimling A, Scolyer RA.
    Am J Surg Pathol; 2013 Jan 06; 37(1):61-5. PubMed ID: 23026937
    [Abstract] [Full Text] [Related]

  • 15. Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays.
    Fisher KE, Cohen C, Siddiqui MT, Palma JF, Lipford EH, Longshore JW.
    Hum Pathol; 2014 Nov 06; 45(11):2281-93. PubMed ID: 25228337
    [Abstract] [Full Text] [Related]

  • 16. Comparative analysis of BRAF, NRAS and c-KIT mutation status between tumor tissues and autologous tumor cell-lines of stage III/IV melanoma.
    Knol AC, Pandolfino MC, Vallée A, Nguyen F, Lella V, Khammari A, Denis M, Puaux AL, Dréno B.
    Exp Dermatol; 2015 Jan 06; 24(1):70-3. PubMed ID: 25363723
    [Abstract] [Full Text] [Related]

  • 17. [Establishment of a highly-metastatic model of human primary melanoma of the small intestine orthotopically transplanted in the small intestine of nude mice].
    Tuo CW, Zhang N, Liu QZ, Yang B, Wang MY.
    Zhonghua Zhong Liu Za Zhi; 2008 Dec 06; 30(12):885-90. PubMed ID: 19173986
    [Abstract] [Full Text] [Related]

  • 18. Deletion in p16INK4a and loss of p16 expression in human skin primary and metastatic melanoma cells.
    Zhang H, Rosdahl I.
    Int J Oncol; 2004 Feb 06; 24(2):331-5. PubMed ID: 14719109
    [Abstract] [Full Text] [Related]

  • 19. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.
    Karim RZ, Li W, Sanki A, Colman MH, Yang YH, Thompson JF, Scolyer RA.
    Int J Surg Pathol; 2009 Oct 06; 17(5):361-7. PubMed ID: 19666944
    [Abstract] [Full Text] [Related]

  • 20. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
    Crende O, Sabatino M, Valcárcel M, Carrascal T, Riestra P, López-Guerrero JA, Nagore E, Mandruzzato S, Wang E, Marincola FM, Vidal-Vanaclocha F.
    Am J Pathol; 2013 Jul 06; 183(1):69-82. PubMed ID: 23707237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 322.